ObamaCare - Hah! More Like ObamaScam 4-March-2014
ObamaCare is probably not about socialized medicine or affordable healthcare for all...
Johnson & Johnson $JNJ Dominic Caruso: SAVE MONEY! FIRE GORSKY! Caruso wants to cut jobs, how about cut the job of the largest financial drain on Johnson & Johnson?
Reasons J&J CEO Alex Gorsky Should Immediately Resign
$JNJ 'Growth' Based on Corruption, Toxic Products, Harmful Devices and Pharma Fraud
Letter to Barack Obama Sent October 10, 2013
Asking him to please sign petition for changes at JNJ.
JNJ Cash Cache Can't Cover Corruption Costs ;o)
Letter to Michael Weinstein of J.P. Morgan and Company regarding Johnson & Johnson 3rd quarter teleconference questions.
Letter to Matthew Dodds of CitiGroup, Inc. regarding Johnson & Johnson 3rd quarter teleconference questions.
How WalMart Ban on Toxic Ingredients Affects Johnson & Johnson $JNJ
Johnson and Johnson: The Global Lawsuit Company
First Insiders, Then Berkshire, Now Trojan and Other Funds Dropping Johnson & Johnson $JNJ Stock
Johnson & Johnson CEO Alex Gorsky and the $5 Billion Risperdal Medicaid Scandal
Johnson & Johnson $3 Billion for Gorsky Project DePuy Hip Harm in U.S., With Lawsuits in at Least 2 More Countries
JNJ CEO Alex Gorsky's Career-Long Cloud of Corruption
Johnson & Johnson Synthes: Corruption, Lawsuits and FDA Violations
Johnson & Johnson Credo Analysis
Johnson & Johnson Consumer Sales Suffer Even More With Products Suspended in South Korea and India
Is there an Obama Connection with J&J?
How Johnson & Johnson Profits From Harmful Products, Bad Drugs and Faulty Devices
Retired J&J CEO Weldon $143.5 M Retirement, $1 M Salary and Bonuses? How's that helping with the high cost of health care?
Johnson & Johnson Settles Shareholder Lawsuit for $23 Mil
Lawsuits Mounting for Harm by Johnson & Johnson Implanted Mesh Products
Johnson & Johnson's Recent Payoff's, I Mean Settlements, Risperdal and Levaquin
The Extremely Expensive Problems Facing Johnson & Johnson
Johnson & Johnson Appears to Have More Lawsuits than Drugs in Their Pipeline
$JNJ Consumer Sales Continue to Drop, 2011 to 2013
Numerous groups have called for boycotts of Johnson & Johnson products for a variety of reasons. In addition, as more mothers in the United States are educated regarding known carcinogens in the U.S. formulation of baby soap, shampoo, powder, lotions, creams and other baby products as well as the same carcinogens in adult care products, it is obvious that the sales of J&J toxic consumer products are suffering as consumers choose less toxic products.
2011 : 2011 consumer sales : U.S. decrease 6.7% / Int increase 7.3 / WW increase 2.0%
http://www.investor.jnj.com/2011annualreport/pdf/JNJ-2011_ManagementsDiscussion_AnalysisSales.pdf page 2 of 11
2012 : 1st quarter consumer sales : U.S. decrease 2.2% / Int decrease 2.5% / WW decrease 2.4%
Worldwide Consumer sales of $3.6 billion for the first quarter represented a decrease of 2.4% versus the prior year consisting of an operational decline of 0.6% and a negative impact from currency of 1.8%. Domestic sales decreased 2.2%. International sales decreased 2.5%, which reflected an operational increase of 0.4% and a negative currency impact of 2.9%.
2012 : 2nd quarter consumer sales : U.S. decrease 1.9% / Int decrease 6.0% / WW decrease 4.6%
Worldwide Consumer sales of $3.6 billion for the second quarter represented a decrease of 4.6% versus the prior year consisting of an operational increase of 0.6% and a negative impact from currency of 5.2%. Domestic sales decreased 1.9%. International sales decreased 6.0%, which reflected an operational increase of 2.0% and a negative currency impact of 8.0%.
2012 : 3rd quarter consumer sales : U.S. decrease 4.3% / Int decrease 6.1% / WW decrease 4.3%
Worldwide Consumer sales of $3.6 billion for the third quarter represented a decrease of 4.3% versus the prior year consisting of an operational increase of 1.0% and a negative impact from currency of 5.3%. Domestic sales decreased 0.4%. International sales decreased 6.1%, which reflected an operational increase of 1.8% and a negative currency impact of 7.9%.
2012 : full year consumer sales : U.S. decrease 2% / Int decrease 3.4% / WW decrease 2.9%
Worldwide Consumer sales of $14.4 billion for the full-year 2012 represented a decrease of 2.9% versus the prior year, consisting of an operational increase of 0.5% and a negative impact from currency of 3.4%. Domestic sales decreased 2.0%; international sales decreased 3.4%, which reflected an operational increase of 1.9% and a negative currency impact of 5.3%.
With yet another recall of Children's Tylenol and yet another undisclosed carcinogen found in yet another baby care product, I don't see Johnson & Johnson consumer sales rebounding any time soon. I don't know, maybe people don't want to risk using products on their children that might harm their precious babies. As people like me continue sharing the risks as fast as we can with other moms so they don't use toxic products, I think sales will likely continue to drop.
Something to consider: As fewer people use toxic products from Johnson & Johnson, the rate of long-term illnesses, such as asthma, allergies, chronic sinus infections, COPD, cancer, low fertility, and such, caused by these products (and the drugs prescribed to deal with side effects of the drugs prescribed) will begin to decline - cutting into Johnson & Johnson medical devices and pharmaceuticals sales ;o)